|Videos|May 10, 2022
What’s Next: Breakthroughs, Advances, and Addressing Unmet Needs
Darrell S. Rigel, MD, MS, FAAD vision of the future treatment innovations for would include medications based on better-targeted immune pathways, effective ways to treat metastatic BCC, and a vaccine to prevent advanced BCC from developing. Rigel addresses these and other developments he sees or would like to see on the horizon.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5















